PROK
PROK
NASDAQ · Biotechnology

Prokidney Corp

$1.64
+0.00 (+0.00%)
As of Aug 9, 10:21 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 4 27%
Sell 1 7%
Price Target
Analyst Price Target +1,108.5% upside
Low Target $13.43
Average Target $19.82
High Target $25.07
Current Price $1.64
Current
$1.64
Target
$19.82
$13.43 $19.82 avg $25.07
Scenario Analysis
Bear Case
$13.43
718.9%
Low target
Base Case
$19.82
+1,108.5%
Avg target
Bull Case
$25.07
+1,428.7%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.48
-52.9% from high
52-Week Low
$1.45
+13.1% from low
Target vs 52W High
$19.82
+469.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.0%